ASGCT Podcast Network

Luigi Naldini, MD, PhD, discusses his intercontinental career and the future of gene editing and use of lentiviral vectors during a one-on-one conversation with ASGCT President Hans-Peter Kiem, MD, PhD. Welcome to the seventh episode of Giants of Gene Therapy! Dr. Naldini is a Professor of Cell and Tissue Biology and of Gene and Cell Therapy at the San Raffaele University School of Medicine and Sc...

Terry Flotte, MD, discusses the early days and possible future of gene therapy, the use of AAV to deliver GT to targeted sites in the body, and his inspiration behind becoming a physician, scientist, and medical school dean. He spoke one-on-one with ASGCT President Hans-Peter Kiem, MD, PhD. Welcome to the sixth episode of Giants of Gene Therapy! Dr. Flotte is the Provost, Dean, and Celia and Isaac...

Jennifer Doudna, PhD, shares her personal journey to co-inventing CRISPR-Cas9 for gene editing and the promise of her discovery, during a one-on-one conversation with ASGCT President Hans-Peter Kiem, MD, PhD. Welcome to the fifth episode of Giants of Gene Therapy! Dr. Doudna has been at UC Berkeley since 2002. She is a professor in the departments of Molecular and Cell Biology and Chemistry, the L...

Drew Weissman, MD, PhD is a pioneer of mRNA technology, which has been used in more than 1 billion administered doses of COVID-19 vaccines. Weissman is the Roberts Family Professor in Vaccine Research, Director of Vaccine Research in the Infectious Disease Division, and the Director of the Institute for RNA Innovation at the University of Pennsylvania and the Perelman School of Medicine. He co-dev...

Carl June, MD, shares his scientific journey, from medical research officer in the U.S. Navy to leader behind the first FDA-approved gene therapy, during his one-on-one conversation with ASGCT President Hans-Peter Kiem, MD, PhD. Welcome to the third episode of Giants of Gene Therapy! Dr. June is a professor in immunotherapy in the Department of Pathology and Laboratory Medicine at University of Pe...

Kathy High, MD, shares her personal and scientific journey, from hemophilia to retinal disease, during her one-on-one conversation with American Society of Gene & Cell Therapy President Hans-Peter Kiem, MD, PhD, in the second episode of ASGCT's Giants of Gene Therapy. Dr. High is the president of therapeutics at AskBio. Before that, she was the co-founder, president, and head of research and d...

David Baltimore, PhD discusses the Nobel Prize, searching for answers on an HIV vaccine, and how gene therapy could change the course of history during his one-on-one conversation with American Society of Gene & Cell Therapy President Hans-Peter Kiem, PhD in the debut episode of ASGCT's Giants of Gene Therapy. Baltimore needs very little introduction. He is president emeritus and distinguished...

Hello, and welcome to the American Society of Gene & Cell Therapy Podcast Network! I’m Hans-Peter Kiem, current president of ASGCT, and I’m hosting our first program, Giants of Gene Therapy. I’ll be interviewing luminaries from the world of cell and gene therapy, from scientific pioneers to Nobel laureates, about a wide range of subjects near to their hearts and expertise. Our first episode, w...